Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic options for systemic sclerosis.

S M Akerkar1, L S Bichile

  • 1Dept. of Rheumatology, Seth GS Medical College and KEM Hospital, Mumbai.

Indian Journal of Dermatology, Venereology and Leprology
|July 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Association between CD4, CD8 and CD25 Cell Counts and SLE in Active Disease and in Remission.

The Journal of the Association of Physicians of India·2017
Same author

Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial.

Journal of postgraduate medicine·2010
Same author

Use of the Internet as a resource of health information by patients: a clinic-based study in the Indian population.

Journal of postgraduate medicine·2005
Same author

Pamidronate--a promising new candidate for the management of spondyloarthropathy.

Indian journal of medical sciences·2005
Same author

Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.

The Journal of the Association of Physicians of India·2005
Same author

Health information on the internet: patient empowerment or patient deceit?

Indian journal of medical sciences·2004
Same journal

Severe combined immunodeficiency (SCID) with pigmentary mosaicism: A coincidental occurrence in a child.

Indian journal of dermatology, venereology and leprology·2026
Same journal

Agminated multifocal eruptive lobular capillary haemangiomas - An uncommon presentation.

Indian journal of dermatology, venereology and leprology·2026
Same journal

Patch testing in India: Are we missing clinically relevant allergens?

Indian journal of dermatology, venereology and leprology·2026
Same journal

Double-loading technique for improved suspension retention on the recipient site in non-cultured epidermal cell suspension (NCES).

Indian journal of dermatology, venereology and leprology·2026
Same journal

Late-onset metastatic melanoma arising from a medium-sized congenital melanocytic naevus.

Indian journal of dermatology, venereology and leprology·2026
Same journal

Custom-compounded glycine-proline jelly for ulcers in prolidase deficiency.

Indian journal of dermatology, venereology and leprology·2026
See all related articles

Systemic sclerosis treatment requires a combined approach targeting vascular damage, immune activation, and fibrogenesis. Angiotensin blockade and cyclophosphamide show promise, improving survival and managing alveolitis in systemic sclerosis patients.

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Biology

Background:

  • Systemic sclerosis is a rare connective tissue disease with complex pathophysiology.
  • Key features include vascular damage, immune cell activation, and excessive fibrogenesis.
  • These distinct pathological processes may necessitate multifaceted therapeutic strategies.

Purpose of the Study:

  • To review current therapeutic strategies for systemic sclerosis.
  • To assess the efficacy of various treatments, including combination therapies.
  • To highlight the importance of individualized treatment approaches.

Main Methods:

  • Critical assessment of clinical trial data for systemic sclerosis therapies.
  • Review of evidence for specific drug classes, such as angiotensin receptor blockers and cyclophosphamide.

Related Experiment Videos

  • Exploration of emerging therapeutic targets, including cytokine modulators.

    • Main Results:

    • Angiotensin blockade significantly improves survival and prevents renal crisis in systemic sclerosis.
    • Cyclophosphamide is definitively effective for treating associated alveolitis.
    • Ongoing research explores novel agents targeting cytokines.

    Conclusions:

    • Current systemic sclerosis therapy is evolving but not yet perfect.
    • Combination therapy offers a more promising approach than single-agent treatment.
    • Individualized treatment based on disease stage, subset, and organ involvement is crucial for effective management.